A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Medical Monitor
Aura Biosciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Westmead Private Hospital
Westmead, New South Wales, Australia
Manish PatelRecruiting - Austin Health
Heidelberg, Victoria, Australia
Joseph IschiaRecruiting - Warringal Private Hospital
Heidelberg, Victoria, Australia
Damien BoltonRecruiting - Penninsula Private Hospital
Langwarrin, Victoria, Australia
George KoufogiannisNot, yet, recruiting - the Royal Melbourne Hospital
Parkville, Victoria, Australia
Paul AndersonNot, yet, recruiting - Hollywood Private Hospital
Nedlands, Western Australia, Australia
Tom ShannonRecruiting
- Arkansas Urology
Little Rock, Arkansas, United States
Terminated - Tower Urology
Los Angeles, California, United States
David JosephsonRecruiting - Saint John'S Cancer Institute
Santa Monica, California, United States
Recruiting - Montefiore Medical Center
The Bronx, New York, United States
Recruiting - Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Recruiting - Urology Associates, P.C.
Nashville, Tennessee, United States
Suspended - Urology Clinics of North Texas
Dallas, Texas, United States
Recruiting - Baylor College of Medicine
Houston, Texas, United States
Recruiting - the University of Texas San Antonio
San Antonio, Texas, United States
Recruiting - the Urology Place
San Antonio, Texas, United States
Recruiting - Urology San Antonio/usa Clinical Trials
San Antonio, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Sept 2022
- Primary completion
- 31 Mar 2027
- Completion
- 31 Mar 2027
- Last update posted
- 15 Apr 2026
- Registered enrollment
- 55
- Registry id
- NCT05483868
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.